Tuesday, June 18 2013 4:51 PM EDT2013-06-18 20:51:51 GMT
LOUISVILLE, Ky. (WDRB) -- Police say a former Highlands Middle School teacher accused of sexually abusing a student at the school is now facing brand new charges stemming from newly uncovered illegal relationshipMore >>
Police say a teacher is facing new charges.More >>
Tuesday, June 18 2013 4:42 PM EDT2013-06-18 20:42:41 GMT
LOUISVILLE, Ky. (WDRB) -- Police say an Indiana teenager handling a rifle accidentally shot his younger brother in the head.The Jennings County Sheriff's Department says the 12-year-old was not responsiveMore >>
Police say an Indiana teenager handling a rifle accidentally shot his younger brother in the head.More >>
Follow the WDRB Newsroom, Reporters and Anchors.More >>
Tweets from the WDRB Newsroom, Reporters and Anchors.More >>
NEW YORK (AP) -- Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes.
The Danish drugmaker says it received a "complete response letter" from the FDA regarding its applications for approval of Tresiba and Ryzodeg, or insulin degludec, on Friday. Such a letter indicates the agency determined the application cannot be approved in its current form.
In November, panel of federal health advisers recommended that the government approve degludec. The FDA is not required to follow the group's advice, but it often does.
Tresiba contains long-acting insulin, and Ryzodeg contains both long- and short-acting insulins.
Diabetics either do not produce enough of the hormone insulin or do not use it efficiently, allowing excess sugar, or glucose, to accumulate in the blood.
